United States · FDA National Drug Code directory
Levothyroxine Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0904-6951_942c00a3-b31c-48d5-a63d-6d394645ee1f
- Product NDC
- 0904-6951
- Form
- TABLET
- Composition / generic term
- Levothyroxine Sodium
- Labeler
- Major Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190320
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — .075 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 CARTON (0904-6951-61) / 1 TABLET in 1 BLISTER PACK · 0904-6951-61
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →